indazoles and eye
indazoles has been researched along with eye in 8 studies
Research
Studies (8)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (37.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (37.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Catanese, B; Martinelli, B; Palmery, M; Valeri, P | 1 |
| Palmery, M; Silvestrini, B; Tita, B; Valeri, P | 1 |
| Ambrogi, F; Ciottoli, GB; Giannotti, P | 1 |
| Graziani, G; Morrone, LA; Pimpinella, G; Romanelli, L; Tita, B; Valeri, P | 1 |
| Buckley, CH; Kelly, PA; O'Brien, C; Ritchie, IM | 1 |
| Acharya, G; Hua, X; Isenhart, LC; Marcano, DC; Pflugfelder, SC; Shin, CS; Yuan, X | 1 |
| Cardona, DM; Cardones, AR; Chao, NJ; Chen, BJ; Di Paolo, JA; Jia, W; Kim, JY; Perez, VL; Poe, JC; Reyes, NJ; Saban, DR; Sarantopoulos, S; Su, H; Sundy, JS | 1 |
| Haniuda, H; Horita, S; Kagawa, Y; Katagiri, M; Nakamura, H; Nakazato, T; Watanabe, M | 1 |
Trials
1 trial(s) available for indazoles and eye
| Article | Year |
|---|---|
Lonidamine plus adriamycin versus adriamycin alone in the adjuvant treatment of recurrent papillary carcinomas of the urinary bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Papillary; Doxorubicin; Eye; Female; Heart; Humans; Indazoles; Male; Middle Aged; Pyrazoles; Urinary Bladder Neoplasms | 1984 |
Other Studies
7 other study(ies) available for indazoles and eye
| Article | Year |
|---|---|
Absorption of bendazac lysine after topical application to the rabbit eye.
Topics: Absorption; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Eye; Indazoles; Male; Pyrazoles; Rabbits | 1987 |
Investigations on the ocular pharmacokinetics of bendazac in rabbits.
Topics: Animals; Anti-Inflammatory Agents; Chromatography, High Pressure Liquid; Eye; Indazoles; Kinetics; Pyrazoles; Rabbits | 1985 |
Ocular absorption and distribution of bendazac after topical administration to rabbits with different vehicles.
Topics: Absorption; Administration, Topical; Animals; Anti-Inflammatory Agents, Non-Steroidal; Cornea; Eye; Hypromellose Derivatives; Indazoles; Male; Methylcellulose; Ophthalmic Solutions; Pharmaceutical Vehicles; Polysaccharides; Rabbits; Tissue Distribution; Viscosity | 1994 |
Possible role for nitric oxide releasing nerves in the regulation of ocular blood flow in the rat.
Topics: Animals; Blood Flow Velocity; Enzyme Inhibitors; Eye; Indazoles; Male; Neurons; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Rats; Rats, Sprague-Dawley | 1998 |
Ocular drug delivery nanowafer with enhanced therapeutic efficacy.
Topics: Animals; Axitinib; Cornea; Corneal Neovascularization; Diffusion; Drug Delivery Systems; Drug Liberation; Eye; Female; Imidazoles; Indazoles; Mice; Mice, Inbred C57BL; Nanotechnology; Protein Kinase Inhibitors; Receptor Protein-Tyrosine Kinases; Wound Healing | 2015 |
SYK inhibitor entospletinib prevents ocular and skin GVHD in mice.
Topics: Administration, Oral; Animals; B-Lymphocytes; Disease Models, Animal; Drug Evaluation, Preclinical; Eye; Female; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Humans; Indazoles; Mice; Protein Kinase Inhibitors; Pyrazines; Skin; Survival Analysis; Syk Kinase; T-Lymphocytes; Treatment Outcome | 2018 |
Species differences in ocular pharmacokinetics and pharmacological activities of regorafenib and pazopanib eye-drops among rats, rabbits and monkeys.
Topics: Angiogenesis Inhibitors; Animals; Choroidal Neovascularization; Crystallization; Disease Models, Animal; Drug Evaluation, Preclinical; Eye; Female; Humans; Indazoles; Macaca fascicularis; Macular Degeneration; Male; Nanoparticles; Ophthalmic Solutions; Particle Size; Phenylurea Compounds; Pyridines; Pyrimidines; Rabbits; Rats; Receptors, Vascular Endothelial Growth Factor; Species Specificity; Sulfonamides; Vascular Endothelial Growth Factor A | 2019 |